Patents by Inventor Alexander Gabibovich GABIBOV

Alexander Gabibovich GABIBOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ULTRA-HIGH PERFORMANCE SCREENING OF BIOLOGICAL OBJECTS
    Publication number: 20230324306
    Abstract: The invention relates to the field of biotechnology and pharmaceutics. Proposed is a method for ultra-high performance screening of biological objects which is based on microfluidic generation of droplets of a biocompatible water-in-oil-in-water double emulsion, and also a method for producing a monodisperse biocompatible water-in-oil-in-water double emulsion. The invention can be used in diagnosing conditions and diseases in mammals, as well as for investigating biological objects.
    Type: Application
    Filed: January 30, 2023
    Publication date: October 12, 2023
    Applicant: SHEMYAKIN-OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY OF THE RUSSIAN ACADEMY OF SCIENCES
    Inventors: Alexander Gabibovich GABIBOV, Ivan Vitalievich SMIRNOV, Stanislav Sergeevich TEREKHOV
  • Method for ultra-high performance screening of biological objects
    Patent number: 11604145
    Abstract: The invention relates to the field of biotechnology and pharmaceutics. Proposed is a method for ultra-high performance screening of biological objects which is based on microfluidic generation of droplets of a biocompatible water-in-oil-in-water double emulsion, and also a method for producing a monodisperse biocompatible water-in-oil-in-water double emulsion. The invention can be used in diagnosing conditions and diseases in mammals, as well as for investigating biological objects.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: March 14, 2023
    Assignee: SHEMYAKIN-OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY OF THE RUSSIAN ACADEMY OF SCIENCES
    Inventors: Alexander Gabibovich Gabibov, Ivan Vitalievich Smirnov, Stanislav Sergeevich Terekhov
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20220018845
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: July 26, 2021
    Publication date: January 20, 2022
    Applicants: HESPERIX SA, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Alexander Gabibovich Gabibov, Richard A. Lerner, Alexey Anatolievich Belogurov, Jia Xie
  • Articles and methods directed to personalized therapy of cancer
    Patent number: 11215618
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: January 4, 2022
    Assignees: HESPERIX SA, The Scripps Research Institute
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20210333282
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: August 3, 2020
    Publication date: October 28, 2021
    Applicants: HESPERIX SA, The Scripps Research Institute
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • REPROGRAMMING OF POLYMORPHONUCLEAR LEUKOCYTES
    Publication number: 20210069242
    Abstract: The application is directed a method of treating a cancer in subject by administering to the subject a therapeutically effective amount of polymorphonuclear leukocytes genetically modified to express a recombinant chimeric antigen receptor (CAR) or T cell receptor (TCR). Further provided are modified polymorphonuclear leukocytes and related compositions for use in such methods.
    Type: Application
    Filed: April 17, 2020
    Publication date: March 11, 2021
    Inventors: Dmitry Dmitrievich GENKIN, Alexey Vyacheslavovich Stepanov, Michael Vladimirovich Dubina, Alexey Alexandrovich Bogdanov, Alexander Gabibovich Gabibov
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20200400676
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: August 3, 2020
    Publication date: December 24, 2020
    Applicants: OPKO Pharmaceuticals, LLC, The Scripps Research Institute, Shemyakin-Ovchinnikov institute of Bioorganic Chemistry, Russian Academy of Sciences, PJSC Pharmsynthez
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20200363420
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: August 3, 2020
    Publication date: November 19, 2020
    Applicants: OPKO Pharmaceuticals, LLC, The Scripps Research Institute, Shemyakin-Ovchinnikov institute of Bioorganic Chemistry, Russian Academy of Sciences, PJSC Pharmsynthez
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20200271657
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: October 4, 2018
    Publication date: August 27, 2020
    Applicants: OPKO Pharmaceuticals, LLC, The Scripps Research Institute, Bioorganic Chemistry, Russian Academy of Sciences, PJSC Pharmsynthez
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • METHOD FOR ULTRA-HIGH PERFORMANCE SCREENING OF BIOLOGICAL OBJECTS
    Publication number: 20200256801
    Abstract: The invention relates to the field of biotechnology and pharmaceutics. Proposed is a method for ultra-high performance screening of biological objects which is based on microfluidic generation of droplets of a biocompatible water-in-oil-in-water double emulsion, and also a method for producing a monodisperse biocompatible water-in-oil-in-water double emulsion. The invention can be used in diagnosing conditions and diseases in mammals, as well as for investigating biological objects.
    Type: Application
    Filed: March 13, 2018
    Publication date: August 13, 2020
    Applicant: SHEMYAKIN-OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY OF THE RUSSIAN ACADEMY OF SCIENCES
    Inventors: Alexander Gabibovich GABIBOV, Ivan Vitalievich SMIRNOV, Stanislav Sergeevich TEREKHOV